Clinical trial

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

NCT07138898

Drugs and interventions used in this trial

27 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Study at a glance

Registry-backed

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov
StatusRECRUITING
Study typeINTERVENTIONAL
Start date2025-12-12
PhasePHASE2
Advertisement

Interventions

LeflunomideDRUG · verified · RxNorm: leflunomide
TacrolimusDRUG · verified · RxNorm: tacrolimus
EtanerceptDRUG · verified · RxNorm: etanercept
AdalimumabDRUG · verified · RxNorm: adalimumab
GolimumabDRUG · verified · RxNorm: golimumab
InfliximabDRUG · verified · RxNorm: infliximab
RituximabBIOLOGICAL
BelimumabBIOLOGICAL
TocilizumabBIOLOGICAL
AnakinraBIOLOGICAL
CanakinumabBIOLOGICAL
AbataceptBIOLOGICAL
SecukinumabBIOLOGICAL
IxekizumabBIOLOGICAL
BimekizumabBIOLOGICAL
UstekinumabBIOLOGICAL
GuselkumabBIOLOGICAL
RisankizumabBIOLOGICAL
TofacitinibDRUG · verified · RxNorm: tofacitinib

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.